Consulta Ltd Increases Stake in HCA Healthcare, Inc. $HCA

Key Points

• Consulta Ltd has increased its stake in HCA Healthcare by 9.1% in Q1, now holding 600,000 shares worth approximately $207.3 million, making it the 3rd largest position in its portfolio.
• HCA Healthcare reported EPS of $6.84 for the last quarter, exceeding estimates of $6.20, alongside revenues of $18.61 billion.
• The company has announced a quarterly dividend of $0.72 per share, which translates to an annualized dividend yield of 0.7%.

Consulta Ltd raised its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 600,000 shares of the company's stock after purchasing an additional 50,000 shares during the period. HCA Healthcare accounts for approximately 14.0% of Consulta Ltd's holdings, making the stock its 3rd biggest holding. Consulta Ltd owned 0.25% of HCA Healthcare worth $207,330,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of HCA. Avantax Advisory Services Inc. lifted its stake in shares of HCA Healthcare by 0.4% in the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after acquiring an additional 32 shares during the period. Horizon Investments LLC grew its stake in HCA Healthcare by 1.1% in the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock valued at $1,097,000 after buying an additional 33 shares during the last quarter. Catalyst Financial Partners LLC boosted its holdings in HCA Healthcare by 4.3% in the 1st quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock valued at $301,000 after purchasing an additional 36 shares during the period. RWA Wealth Partners LLC lifted its holdings in shares of HCA Healthcare by 2.0% during the 1st quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company's stock worth $658,000 after acquiring an additional 37 shares during the period. Finally, Moors & Cabot Inc. increased its position in shares of HCA Healthcare by 4.8% during the 1st quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock worth $297,000 after purchasing an additional 39 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Cantor Fitzgerald reiterated an "overweight" rating and set a $444.00 price target on shares of HCA Healthcare in a research report on Tuesday, August 26th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Wells Fargo & Company cut their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 14th. Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Finally, Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $401.83.

HCA Healthcare Stock Down 0.8%

HCA traded down $3.17 during mid-day trading on Monday, reaching $404.11. 996,401 shares of the stock were exchanged, compared to its average volume of 1,110,551. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock has a market capitalization of $94.56 billion, a PE ratio of 16.45, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41. The company has a 50 day moving average price of $376.92 and a two-hundred day moving average price of $357.19. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.